In in vitro anti-inflammatory studies, dieckol upregulates hemeoxygenase-1 (HO-1), mediating anti-inflammatory effects in macrophages, and inhibits PI3 K and AKT phosphorylation in colon cancer cells, thereby impeding cancer cell proliferation and migration [70,71]. This evidence concerns the gene AKT1 and malignant colon neoplasm.